SpaceX Joins the Nasdaq-100 on July 7. The Real Trade Is What Happens After.
Forced buying, a tiny float, and a valuation debate that will define SPCX for the rest of 2026.
Eli Lilly Just Unlocked Its Biggest Market Yet
Medicare GLP-1 access went live July 1. The growth story is just getting started.
Vertiv Is Up 73% in 2026. Now Comes the Hard Part.
Q2 earnings are *estimated* for July 29. The backlog is massive. The valuation is not cheap.
Broadcom Is Down 20% From Its High. The $100 Billion Question Is What Happens Next.
Record AI revenue, a post-earnings selloff, and a September 3 earnings date that now defines the trade.
GS Reports July 14. The Stock Just Hit an All-Time High and Nobody Is Talking About the Real Risk.
Goldman’s dividend is headed to $5.00 a quarter. Its M&A machine is running hot. So why is the options market nervous?
Concentrix Just Imploded. The Real Warning Is Sector-Wide.
AI is not saving the BPO industry. It is quietly dismantling it.
Exxon and Chevron Had a Monster Year. Then General License X Happened.
A Treasury authorization just unlocked Iranian crude, and energy’s biggest 2026 winners are paying for it now.
The Market Hiding Inside the Market
Manufacturing just hit a 4-year high. The S&P 500 barely noticed.
Healthcare Just Surged 3% Today. The Split Inside the Sector Is the Real Story.
XLV is leading, but not every part of healthcare is going the same direction.
The $600 Billion Tab Nobody Can Pay Right Now
OpenAI’s IPO delay just exposed the most dangerous assumption in the entire AI trade.